Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Source Summary
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group...
This page is a short summary of coverage from SiliconANGLE News. Open the publisher’s report below for the full story and context.
Related Tech Briefings
SiliconANGLE News